Ketogenic diet shows promise in addressing hormonal imbalance associated with PCOS

Researchers performed a meta-analysis on the impact of ketogenic diets on polycystic ovary syndrome (PCOS).

Accord BioPharma’s HERCESSI gets FDA approval

HERCESSI is approved for treating HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric or gastroesophageal junction adenocarcinoma. Credit: Lightspring/Shutterstock. Accord BioPharma, the speciality division

September 19, 2024

Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP) – Biotech Investments

EQS-News: Biotest AG / Key word(s): Study Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP) 12.12.2023 / 09:00 CET/CEST

December 13, 2023

Embracing SDOH Data Monitoring for Transformative Healthcare

Christine Lee, Head of Health Partnerships at AnalyticsIQ Understanding the multifaceted dimensions of patient wellness goes beyond the medical symptoms presented in a clinical setting.

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.